WASHINGTON:A U.S. government advisory panel endorsed widespread use of Pfizer’s coronavirus vaccine Thursday, putting the country just one step away from launching an epic vaccination campaign against the outbreak that has killed close to 300,000 Americans.
Shots could begin within days, depending on how quickly the Food and Drug Administration signs off, as expected, on the expert committee’s recommendation.
“This is a light at the end of the long tunnel of this pandemic,” declared Dr. Sally Goza, president of the American Academy of Pediatrics.
In a 17-4 vote with one abstention, the government advisers concluded that the vaccine from Pfizer and its German partner BioNTech appears safe and effective for emergency use in adults and teenagers 16 and over.
That endorsement came despite questions about allergic reactions in two people who received the vaccine earlier this week when Britain became the first country to begin dispensing the Pfizer-BioNTech shot.
While there are a number of remaining unknowns about the vaccine, in an emergency, “the question is whether you know enough” to press ahead, said panel member Dr. Paul Offit of Children’s Hospital of Philadelphia. He concluded that the potential benefits outweigh the risks.
The decision came as COVID-19 cases surge to ever-higher levels across the U.S., with deaths setting an all-time, one-day record of more than 3,100 on Wednesday.
Pfizer has said it will have about 25 million doses of the two-shot vaccine for the U.S. by the end of December. But the initial supplies will be reserved primarily for health care workers and nursing home residents, with other vulnerable groups next in line until ramped-up production enables shots to become widely available on demand — something that will probably not happen until the spring.
Next week, the FDA will review a second vaccine, from Moderna and the National Institutes of Health, that appears about as protective as Pfizer-BioNTech’s shot. A third candidate, from Johnson & Johnson, which would require just one dose, is working its way through the pipeline. Behind that is a candidate from AstraZeneca and Oxford University.
U.S. health experts are hoping a combination of vaccines will ultimately enable the U.S. to conquer the outbreak.
Still, experts estimate at least 70% of the U.S. population will have to be vaccinated to achieve herd immunity, the point at which the virus can be held in check. That means it could be several months before things start to get back to normal and Americans can put away their masks.
All eyes now turn to the FDA staff scientists who will make the final decision of whether to press ahead with large-scale immunizations with Pfizer-BioNTech's vaccine. The FDA’s vaccine director, Dr. Peter Marks, said a decision would come within “days to a week.”
Dr. William Moss of Johns Hopkins University, who was not involved in the expert panel's review, welcomed the outcome, saying, “Given how bad the pandemic is now, we need to move.”
The independent review by non-government experts in vaccine development, infectious diseases and medical statistics was considered critical to boosting Americans’ confidence in the safety of the shot, which was developed at breakneck speed less than a year after the virus was identified.
Regulators in both Britain and Canada have already approved the vaccine for use in their countries, and President Donald Trump and White House officials have complained for weeks that the FDA was moving too slowly.
“Americans want us to do a scientific review, but I think they also want us to make sure we’re not wasting time on paperwork as opposed to going forward with the decision,” FDA Commissioner Stephen Hahn said before the meeting.
FDA scientists issued a glowing review of the vaccine earlier in the week. Agency staffers said data from Pfizer’s ongoing study of 44,000 people showed strong protection across different age groups, races and health conditions with no major, unexpected safety problems.
The Pfizer-BioNTech shot remains experimental because that final-stage study isn’t complete. As a result, the expert panel wrestled with a list of questions that have yet to be answered.
For example, while the vaccine is more than 90% effective in blocking the symptoms of COVID-19, the FDA’s advisers stressed it is not yet clear whether it can stop the silent, symptomless spread that accounts for roughly half of all cases.
“Even though the individual efficacy of this vaccine is very, very, very high, you really as of right now do not have any evidence” that it will lower transmission, said Dr. Patrick Moore of the University of Pittsburgh. He urged Pfizer to take additional steps to answer that question.
Several of the dissenting panel members objected to authorizing the shot for 16- and 17-year-olds, given their small numbers in the study and the low risk they face from COVID-19.
Members worried, too, that Pfizer will lose its opportunity to answer critical questions once it begins offering the real vaccine to study participants who had been getting dummy shots up to now.
The company proposed gradually moving those patients to the vaccine group, with priority based on age, health conditions and other factors. Under that plan, 70-year-old participants would cross over before healthy 30-year-olds.
Pfizer must still show whether the vaccine works in children younger than 16 and in pregnant women.
On the safety front, as widespread vaccinations begin, the first recipients will be closely tracked by government health authorities, since studies in tens of thousands of people can’t detect side effects that strike 1 in a million. Hanging over the meeting were the British allergic reactions and a warning from authorities there that people with a history of serious reactions shouldn’t get the vaccine for now.
Pfizer representatives said they have seen no signs of allergic reactions in their trial. But some of the FDA advisers fear the British warning will deter millions of Americans with allergies who might benefit from the COVID-19 vaccine from giving it a try and urged additional studies to try to settle the issue.
“This issue is not going to die until we have better data,” Offit said.
AP Newsroom
Fri Dec 11 2020
![US panel endorses widespread use of Pfizer COVID-19 vaccine US panel endorses widespread use of Pfizer COVID-19 vaccine](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2020-12/41606892895_TBCOVIDVACCINE.jpg)
The Pfizer-BioNTech shot remains experimental because that final-stage study isnt complete. As a result, the expert panel wrestled with a list of questions that have yet to be answered. - REUTERS
![PPZ-MAIWP catat RM511 juta kutipan zakat tahun ini, naik 10 peratus PPZ-MAIWP catat RM511 juta kutipan zakat tahun ini, naik 10 peratus](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-04/61714481430_TBNAIM.jpg)
PPZ-MAIWP catat RM511 juta kutipan zakat tahun ini, naik 10 peratus
PPZ-MAIWP mencatat kutipan zakat sebanyak RM511 juta dari Januari hingga Jun tahun ini dengan peningkatan sebanyak 10 peratus berbanding tempoh sama pada 2023.
![Misi ekonomi produk agrikomoditi ke India perkukuh hubungan dua hala Misi ekonomi produk agrikomoditi ke India perkukuh hubungan dua hala](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/61721130378_JohariAbdulGhani.jpg)
Misi ekonomi produk agrikomoditi ke India perkukuh hubungan dua hala
KPK akan mengadakan Misi Ekonomi Produk Agrikomoditi Malaysia ke India pada 17-18 Julai ini.
![Golongan belia pemacu penting bentuk masa depan industri pembuatan Malaysia - FMM Golongan belia pemacu penting bentuk masa depan industri pembuatan Malaysia - FMM](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-05/41715247870_SohThianLaijpg.jpg)
Golongan belia pemacu penting bentuk masa depan industri pembuatan Malaysia - FMM
Pemimpin perniagaan dan usahawan daripada golongan belia merupakan pemacu penting yang akan membentuk masa depan industri pembuatan Malaysia, kata Presiden Persekutuan Pekilang-Pekilang Malaysia.
AWANI Tonight: 16 July 2024
#AWANITonight with @Hafiz_Marzukhi
1. Govt mulls amending Penal Code to deal with cyberbullying
2. England's Southgate resigns after Euro 2024 Final defeat
#AWANIEnglish #AWANINews
1. Govt mulls amending Penal Code to deal with cyberbullying
2. England's Southgate resigns after Euro 2024 Final defeat
#AWANIEnglish #AWANINews
![9,241 pelajar Palestin terbunuh dalam serangan Israel sejak 7 Oktober 9,241 pelajar Palestin terbunuh dalam serangan Israel sejak 7 Oktober](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-06/81718630490_Smokerises.jpg)
9,241 pelajar Palestin terbunuh dalam serangan Israel sejak 7 Oktober
9,318 pelajar terbunuh dan 14,671 lagi cedera di Semenanjung Gaza manakala di Tebing Barat, 103 pelajar terbunuh dan 505 lagi cedera.
![Penumpang Singapore Airlines meningkat hampir 14 peratus pada Jun Penumpang Singapore Airlines meningkat hampir 14 peratus pada Jun](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/61721142800_AirbusA.jpg)
Penumpang Singapore Airlines meningkat hampir 14 peratus pada Jun
Rangkaian penumpang Kumpulan SIA meliputi 125 destinasi setakat Jun dan rangkaian kargo terdiri daripada 129 destinasi.
![Empat individu termasuk pasangan pempengaruh bebas tahanan reman Empat individu termasuk pasangan pempengaruh bebas tahanan reman](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-05/41716613114_TBsprm.jpg)
Empat individu termasuk pasangan pempengaruh bebas tahanan reman
Kesemua individu juga perlu hadir ke pejabat Suruhanjaya Pencegahan Rasuah Malaysia (SPRM) sebulan sekali untuk melaporkan diri.
![KPT alu-alukan syor PAC guna garis panduan pelaburan universiti awam untuk anak syarikat KPT alu-alukan syor PAC guna garis panduan pelaburan universiti awam untuk anak syarikat](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/81719822088_ZambryAbdKadir.jpg)
KPT alu-alukan syor PAC guna garis panduan pelaburan universiti awam untuk anak syarikat
KPT mengalu-alukan cadangan PAC berhubung pelaksanaan dan pemakaian Garis Panduan Pelaburan dan Pembiayaan oleh Universiti Awam 2024, kepada anak-anak syarikat di bawah seliaan kementerian itu.
![SUKMA 2024: Sepak takraw wanita mungkin digugurkan SUKMA 2024: Sepak takraw wanita mungkin digugurkan](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/61720679430_AbdulKarimRahman.jpg)
SUKMA 2024: Sepak takraw wanita mungkin digugurkan
Sepak takraw wanita berpasukan berkemungkinan akan digugurkan daripada senarai acara temasya Sukan Malaysia (SUKMA) 2024 berikutan jumlah penyertaan kurang daripada jumlah minimum yang ditetapkan.
10 Berita Pilihan - (16 Julai 2024)
Antara pelbagai berita dalam dan luar negara yang disiarkan di Astro AWANI, berikut adalah yang paling menjadi tumpuan sepanjang hari ini.
![Ringgit susut berbanding dolar US pada penutup Ringgit susut berbanding dolar US pada penutup](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-04/41713876066_TBringgitmalaysia.jpg)
Ringgit susut berbanding dolar US pada penutup
Pada 6 petang, ringgit susut lagi kepada 4.6745/6790 berbanding dolar AS daripada 4.6725/6745 semasa ditutup semalam.
![Penampilan pertama Trump di konvensyen GOP selepas terselamat cubaan bunuh Penampilan pertama Trump di konvensyen GOP selepas terselamat cubaan bunuh](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/71721113188_DonaldTrump.jpg)
Penampilan pertama Trump di konvensyen GOP selepas terselamat cubaan bunuh
Donald Trump menghadiri Konvensyen Kebangsaan Republikan pada malam Isnin, penampilan umum pertamanya sejak terselamat daripada cubaan bunuh.
![Trump umum Senator JD Vance sebagai calon Naib Presidennya Trump umum Senator JD Vance sebagai calon Naib Presidennya](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/81721107129_DonaldTrumpJDV.jpg)
Trump umum Senator JD Vance sebagai calon Naib Presidennya
Bekas Presiden Amerika Syarikat Donald Trump mengumumkan Senator Ohio JD Vance akan menjadi calon Naib Presidennya dalam pilihan raya 2024.
![Tiada tempat untuk keganasan politik dalam demokrasi AS - Obama Tiada tempat untuk keganasan politik dalam demokrasi AS - Obama](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/81721093818_JoeBiden.jpg)
Tiada tempat untuk keganasan politik dalam demokrasi AS - Obama
Kenyataan Obama mengundang kecaman warganet terutamanya istilah 'keganasan politik' yang dikatakan menunjukkan sisi hipokrasi Washington.
![Mahkamah AS tolak pertuduhan tambahan dalam kes dokumen sulit Trump Mahkamah AS tolak pertuduhan tambahan dalam kes dokumen sulit Trump](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/71721080824_chargingdocument.jpg)
Mahkamah AS tolak pertuduhan tambahan dalam kes dokumen sulit Trump
Permohonan Trump untuk menolak pertuduhan berdasarkan pelantikan dan pembiayaan tidak sah 'Special Counsel' Jack Smith diluluskan.
![Berita antarabangsa pilihan sepanjang hari ini Berita antarabangsa pilihan sepanjang hari ini](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2023-12/61702135893_TBBERITAx.jpg)
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
![Sokongan belian asing dorong Bursa Malaysia ditutup tinggi Sokongan belian asing dorong Bursa Malaysia ditutup tinggi](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-04/61714480297_tbbursamalaysialog.jpg)
Sokongan belian asing dorong Bursa Malaysia ditutup tinggi
Bursa Malaysia ditutup tinggi pada hari dagangan pertama minggu ini berikutan sokongan belian asing yang berterusan, dalam keadaan prestasi pasaran serantau yang bercampur-campur.
![Biden seru redakan retorik politik di AS selepas cubaan bunuh Trump Biden seru redakan retorik politik di AS selepas cubaan bunuh Trump](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/61721019915_JoeBiden.jpg)
Biden seru redakan retorik politik di AS selepas cubaan bunuh Trump
Sudah tiba masanya untuk meredakan retorik politik di Amerika Syarikat (AS), kata Presiden Joe Biden semasa ucapan mengenai cubaan membunuh bekas Presiden Donald Trump.
![Bahan letupan ditemukan dalam kereta suspek penembak Trump - Laporan Bahan letupan ditemukan dalam kereta suspek penembak Trump - Laporan](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/61721018676_ThomasMatthewCroo.jpg)
Bahan letupan ditemukan dalam kereta suspek penembak Trump - Laporan
Pihak berkuasa menemukan bahan letupan dalam kereta yang dipandu lelaki berusia 20 tahun yang didakwa cuba membunuh bekas Presiden Donald Trump semasa perhimpunan kempennya di Pennsylvania.
![Biden gesa siasatan bebas berhubung insiden tembakan Trump Biden gesa siasatan bebas berhubung insiden tembakan Trump](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/41721016439_JoeBiden.jpg)
Biden gesa siasatan bebas berhubung insiden tembakan Trump
Presiden Amerika Syarikat (AS) Joe Biden menyeru agar rakyat negara itu bersatu susulan cubaan membunuh terhadap Donald Trump.